Meta-Analysis of Randomized Trials on Remote Ischemic Conditioning During Primary Percutaneous Coronary Intervention

Ayman Elbadawi1, Le Dung Ha2, Ahmed S Abuzaid3

  • 1Department of Medicine, Rochester General Hospital, Rochester, New York; Department of Cardiovascular Medicine, Ain Shams University, Cairo, Egypt.

Insights

Remote ischemic conditioning (RIC) may improve outcomes for ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). This meta-analysis found RIC reduced infarct size, major adverse events, and improved ST-segment resolution.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Ischemia-Reperfusion Research

Background:

  • Ischemia/reperfusion injury significantly impacts infarct size after primary percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI).
  • The effectiveness of remote ischemic conditioning (RIC) in mitigating this injury remains inconsistently reported, necessitating a comprehensive overview.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the efficacy of RIC in patients with STEMI undergoing primary PCI.
  • To synthesize evidence on RIC's impact on infarct size, cardiac events, and procedural outcomes.

Main Methods:

  • Included randomized controlled trials comparing RIC to standard of care in STEMI patients undergoing primary PCI.
  • Final analysis comprised 8 trials with 1,083 participants.

Main Results:

  • RIC significantly reduced infarct size (biomarker release: SMD = -0.23, p=0.001) and major adverse cardiac and cerebrovascular events (RR = 0.57, p=0.003).
  • Improved ST-segment resolution rates were observed with RIC (54% vs 30%, RR = 1.78, p<0.001).
  • No significant difference in infarct size by cardiac imaging (SMD = -0.15, p=0.36) or Thrombolysis In Myocardial Infarction-III flow (RR = 0.99, p=0.81) was noted.

Conclusions:

  • Remote ischemic conditioning demonstrates potential in improving cardiovascular outcomes for STEMI patients undergoing primary PCI.
  • Evidence suggests RIC reduces biomarker-indicated infarct size, major adverse events, and enhances ST-segment resolution.

Related Concept Videos